DRKS00027898招募中不适用
Serial Serum Neurofilament measurements for the diagnosis and prediction of chemotherapy-induced polyneuropathy - SENSE-CIP
Charité Universitätsmedizin BerlinKlinik für Neurologie0 个研究点目标入组 70 人开始时间: 2022年2月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •written informed consent is present
- •- the patient is capable of giving consent (he/she is capable of understanding the nature, possible benefits and possible risks of a participation in the study)
- •- minimum age 18 years
- •- The participant belongs to one of the following groups:
- •(a) planned neurotoxic chemotherapy (e.g. (nab-)paclitaxel, cisplatin, oxaliplatin, carboplatin, vincristine, bortezomib or a combination of these)
- •b) Diagnosis of gynecologic malignancy and planned nerve-sparing surgery
- •c) Diagnosis of uterus myoma and/or endometriosis and planned laparascopy/laparotomy
排除标准
- •- the participant is not capable of giving consent
- •- the participant is legally detained in an official institution
- •- the participant has a pre-existing polyneuropathy with a TNSc of >5 points at V0 or V1
研究者
相似试验
招募中
Unknown
Estimation of levels of Serum neurofilament light chains in leprosy patients with peripheral neuropathyCTRI/2024/04/065814Indian Association of Dermatology, Venereology and Leprosy
招募中
不适用
Pilot-study: serum neurofilament light chains as a marker for neurological manifestation in fabry diseaseE75.2Other sphingolipidosisFabry DiseaseDRKS00024662Medizinische Universität Wien90
已完成
不适用
An observational study of serum and cerebrospinal fluid concentrations of osimertinib for the treatment of lung cancer harboring EGFR activating and T790M mutations.ung CancerJPRN-UMIN000024327Miyagi Cancer Center40
终止
不适用
Neurofilaments for NEDA Assessing in MSMultiple SclerosisNCT03250169Queen Mary University of London21
进行中（未招募）
不适用
Assessment of NfL and GFAP Levels, Atrophy of the Macula GCC by OCT and Whole Brain Atrophy by MRI to Predict Evolution of Neurological Disability in MS PatientsMultiple SclerosisNCT04860947Centre Hospitalier Universitaire de Nīmes200